Clinton Health Access Initiative
The Senior Program Manager leads operational and technical aspects of CHAI's cervical cancer program, overseeing country support, costing, financing, and diagnostics strategy, including AI‑assisted screening tools. The role manages a small team, coordinates with global partners and donors, and contributes to fundraising and program strategy to advance cervical cancer elimination in low‑ and middle‑income countries.
Headquarters
Boston, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2002
Clinton Health Access Initiative (CHAI) is a global health non‑profit that works with governments, partners, and markets to save lives, reduce disease burden, and strengthen health systems. CHAI negotiates lower prices and expands access to essential medicines, diagnostics, and vaccines while providing technical assistance to build supply chains, data systems, and clinical capacity. It focuses on market‑shaping, policy support, and analytic tools across priorities such as HIV, TB, malaria, maternal and child health, and immunization. CHAI’s programs emphasize measurable, sustainable, country‑led improvements in health outcomes.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Clinton Health Access Initiative.
Clinton Health Access Initiative didn’t post a salary, so this is our estimate from similar listings.
22% below the average for this role
Postdoctoral Research Fellow
The University of British Columbia
Senior Program Officer (SPO), AI & Digital Health Delivery
Gates Ventures
TB Diagnostics R&D Portfolio Lead
Gates Ventures
Program Administrator I
Dana-Farber Cancer Institute
Deputy Director, High Impact Countries
Gates Ventures
Senior Program Officer, TB/HIV Diagnostics Research & Development
Gates Ventures